As of March 23, 2026, Candel Therapeutics's top three insider holders are Paul B Manning (Director, 2.76Mn shares), Paul B Manning (Director, 1.68Mn shares), Laura K. Aguilar (TenPercentOwner, 1.03Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Paul B Manning | 0 | 2,763,527 | 26 Feb, 2026 | |
| Paul B Manning | 1,681,000 | 0 | 04 Aug, 2021 | |
| Laura K. Aguilar | 1,033,840 | 0 | 10 May, 2022 | |
| Estuardo Aguilar-Cordova | 162,929 | 120,861 | 25 Feb, 2025 | |
| Paul Peter Tak | Chief Executive Officer | 268,566 | 0 | 26 Jun, 2025 |
| Christopher Martell | 152,000 | 0 | 12 Dec, 2022 | |
| Christopher Martell | 0 | 111,349 | 26 Jun, 2025 | |
| Francesca Barone | Chief Scientific Officer | 100,809 | 0 | 26 Jun, 2025 |
| Seshu Tyagarajan | Chief Technology Officer | 90,865 | 0 | 26 Jun, 2025 |
| Joseph C Papa | 0 | 64,239 | 26 Jun, 2025 | |
| William Garrett Nichols | Chief Medical Officer | 52,493 | 0 | 30 Jul, 2025 |
| Charles Schoch | Chief Financial Officer | 43,391 | 0 | 26 Jun, 2025 |
| Joseph C Papa | 38,032 | 0 | 12 Dec, 2022 | |
| John J Canepa | Chief Financial Officer | 10,125 | 0 | 02 Aug, 2021 |
| Diem Nguyen | 10,000 | 0 | 02 Aug, 2021 | |
| Nathan Caffo | Chief Business Officer | 6,000 | 0 | 02 Aug, 2021 |
| Gary J. Nabel | 5,353 | 0 | 26 Jun, 2025 | |
| Nicoletta Loggia | 2,141 | 0 | 26 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Feb, 2026 | Paul B Manning | Common Stock | A | 550,458 | $5.45 | 2,763,527 | I | P |
| 26 Jan, 2026 | Francesca Barone | Stock Option (Right to Buy) | A | 232,000 | $0.00 | 232,000 | D | A |
| 26 Jan, 2026 | William Garrett Nichols | Stock Option (Right to Buy) | A | 136,500 | $0.00 | 136,500 | D | A |
| 26 Jan, 2026 | Seshu Tyagarajan | Stock Option (Right to Buy) | A | 154,000 | $0.00 | 154,000 | D | A |
| 26 Jan, 2026 | Charles Schoch | Stock Option (Right to Buy) | A | 232,000 | $0.00 | 232,000 | D | A |
| 26 Jan, 2026 | Paul Peter Tak | Stock Option (Right to Buy) | A | 629,000 | $0.00 | 629,000 | D | A |
| 28 Jul, 2025 | William Garrett Nichols | Common Stock | A | 937 | $1.29 | 53,430 | D | M |
| 28 Jul, 2025 | William Garrett Nichols | Common Stock | D | 937 | $6.98 | 52,493 | D | S |
| 28 Jul, 2025 | William Garrett Nichols | Stock Option (Right to Buy) | D | 937 | $0.00 | 29,377 | D | M |
| 30 Jun, 2025 | William Garrett Nichols | Common Stock | A | 781 | $1.29 | 53,274 | D | M |
| 30 Jun, 2025 | William Garrett Nichols | Common Stock | D | 781 | $5.04 | 52,493 | D | S |
| 30 Jun, 2025 | William Garrett Nichols | Stock Option (Right to Buy) | D | 781 | $0.00 | 30,314 | D | M |
| 25 Jun, 2025 | Gary J. Nabel | Common Stock | A | 5,353 | $4.67 | 5,353 | D | A |
| 25 Jun, 2025 | Francesca Barone | Common Stock | A | 4,282 | $4.67 | 100,809 | D | A |
| 25 Jun, 2025 | Paul Peter Tak | Common Stock | A | 42,826 | $4.67 | 268,566 | D | A |
| 25 Jun, 2025 | Seshu Tyagarajan | Common Stock | A | 5,353 | $4.67 | 90,865 | D | A |
| 25 Jun, 2025 | Paul B Manning | Common Stock | A | 1,070,663 | $4.67 | 2,213,069 | I | A |
| 25 Jun, 2025 | Joseph C Papa | Common Stock | A | 64,239 | $4.67 | 64,239 | I | A |
| 25 Jun, 2025 | Christopher Martell | Common Stock | A | 111,349 | $4.67 | 111,349 | I | A |
| 25 Jun, 2025 | Charles Schoch | Common Stock | A | 5,353 | $4.67 | 43,391 | D | A |